Sean Kearney is the CEO of UberDoc, an innovative healthcare platform empowering patients to connect with top physicians instantly, free from insurance or referral restrictions. Sean brings more than a decade of experience scaling early-stage healthcare technology companies. He has led organizations through high-growth phases including exits via IPO and M&A, and helped build companies such as Lemonaid Health (acquired by 23andMe), Invitae (NYSE: NVTA), and RespondWell (acquired by Zimmer Biomet). He previously served as CFO at Genomenon, Inc., where he played a pivotal role in expanding adoption of the company's genomic intelligence solutions to leading clinical testing labs and pharmaceutical companies.
If HSAs and FSAs were functioning as originally intended, the rising out-of-pocket costs faced by most Americans would be met with increased financial fluency and agency.